复发性非创伤性脑出血的位置与时机
该队列研究汇总2002至2021年欧洲医院队列中733例至少1次复发的脑小血管病相关脑出血患者,分析复发事件与首发事件的位置关系。结果显示,脑叶首发脑出血和脑淀粉样血管病与邻近复发相关,而邻近复发及既往脑叶或凸面蛛网膜下腔出血与更短复发时间相关。作者认为局部组织因素可能促进复发,针对局部血管病变或是潜在新治疗靶点。
要点
- 脑叶首发脑出血与邻近复发的校正比值比为2.08(95%CI 1.32至3.27)。
- 脑淀粉样血管病与邻近复发的校正比值比为2.21(95%CI 1.57至3.11)。
- 邻近复发中位时间1.25年,远隔复发中位时间2.21年。
核心结论
- 研究发现早期复发和脑淀粉样血管病与邻近脑出血复发相关。
- 这些发现提示区域组织因素可能促进复发,识别和靶向局部血管病变可能是潜在的新治疗靶点。
研究设计与样本
- 该研究为队列研究,是对2002至2021年欧洲医院队列个体数据的汇总分析。
- 纳入733例至少有2次临床可区分(≥1次复发)的小血管病相关脑出血事件患者。
- 数据分析于2023年12月至2024年12月进行。
主要发现
- 共纳入733例患者(中位[IQR]年龄72.4[65.2至79.0]岁;女性346例[47.2%]),共1616次脑出血事件,包括733次首发和883次复发事件(复发范围1至6次),中位(IQR)随访2.53(0.66至4.92)年。
- 340例患者(46.4%)为邻近脑出血,393例患者(53.6%)为远隔脑出血;复发事件中邻近脑出血476次,远隔脑出血407次。
- 多变量回归分析中,脑叶首发脑出血(校正比值比[aOR] 2.08;95%CI 1.32至3.27)和首发脑出血时脑淀粉样血管病(aOR 2.21;95%CI 1.57至3.11)与邻近脑出血的比值升高相关,小脑首发脑出血与邻近脑出血的比值降低相关(aOR 0.25;95%CI 0.07至0.89)。
- 邻近脑出血的中位(IQR)复发时间为1.25(0.36至3.38)年,远隔脑出血为2.21(0.66至4.85)年。
- 既往脑叶或凸面蛛网膜下腔出血(系数-0.75;95%CI -1.25至-0.25;P=.003)、邻近脑出血(系数-0.60;95%CI -1.02至-0.18;P=.005)和既往脑出血事件数(每增加1次事件的系数-0.62;95%CI -0.93至-0.32;P<.001)与更短的复发时间独立相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: : The spatial and temporal distribution of intracerebral hemorrhage (ICH) recurrence are largely unknown. OBJECTIVE: To assess timing and location of recurrent ICH events in relation to the index ICH event (adjacent ICH [adjICH] vs remote ICH [remICH]). DESIGN, SETTING, AND PARTICIPANTS: This cohort study was a pooled analysis of individual cohort studies from 2002 to 2021 among hospital-based European cohorts. Patients with 2 or more clinically distinguishable (≥1 recurrent) small vessel disease-related ICH events were included. Data analysis was performed from December 2023 to December 2024. EXPOSURES: ICH location and underlying small vessel disease type. MAIN OUTCOMES AND MEASURES: The primary outcome was adjICH, defined by anatomical ICH location and side, and the secondary outcome was time to recurrence. Multivariable regression analyses were conducted adjusting for ICH location, cerebral amyloid angiopathy according to Boston 2.0 or simplified Edinburgh criteria, convexity subarachnoid hemorrhage extension, hypertension, and antihypertensive treatment, including an interaction term for hypertension and antihypertensive treatment. RESULTS: Among 733 patients (median [IQR] age, 72.4 [65.2 to 79.0] years; 346 female [47.2%]), there were 1616 ICH events, including 733 index and 883 recurrent ICH events (range, 1 to 6 recurrences) over a median (IQR) follow-up of 2.53 (0.66 to 4.92) years. There were 340 patients (46.4%) with adjICH and 393 patients (53.6%) with remICH. Among recurrent ICH events, there were 476 adjICH events and 407 remICH events. In multivariable regression analyses, lobar index ICH (adjusted odds ratio [aOR], 2.08; 95% CI, 1.32 to 3.27) and cerebral amyloid angiopathy at index ICH (aOR, 2.21; 95% CI, 1.57 to 3.11) were associated with higher odds of adjICH, while cerebellar index ICH was associated with lower odds of adjICH (aOR, 0.25; 95% CI, 0.07 to 0.89). The median (IQR) time to recurrence was 1.25 (0.36 to 3.38) years for adjICH and 2.21 (0.66 to 4.85) years for remICH. Previous lobar or convexity subarachnoid hemorrhage (coefficient, -0.75; 95% CI, -1.25 to -0.25; P = .003 ), adjICH (coefficient, -0.60; 95% CI, -1.02 to -0.18; P = .005), and the number of previous ICH events (coefficient per 1-event increase, -0.62; 95% CI, -0.93 to -0.32; P < .001) were independently associated with a shorter time to recurrence. CONCLUSIONS AND RELEVANCE: This study found that early recurrence and cerebral amyloid angiopathy were associated with adjICH. These findings suggest that regional, tissue-based factors may facilitate recurrence and that identifying and targeting local vasculopathic changes may represent potential novel treatment targets.
引用
- Goeldlin MB, Fandler-Höfler S, Pezzini A, et al. Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage. JAMA Neurol. 2025. PMID: 40029641. doi:10.1001/jamaneurol.2025.0026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。